SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001575872-23-001294 from INSPIRE VETERINARY PARTNERS, INC. (IVPR)

INSPIRE VETERINARY PARTNERS, INC.
Date: Aug. 9, 2023 · CIK: 0001939365 · Accession: 0001575872-23-001294

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
August 14, 2023
Author
Director
Form
CORRESP
Company
INSPIRE VETERINARY PARTNERS, INC.

Letter

Re: Inspire Veteniary Partners, Inc.

August 9, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333- 271198

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Spartan Capital Securities, LLC, as representative of the several underwriters, hereby joins Inspire Veteniary Partners Inc., (the “Company”) in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333- 271198) (the “Registration Statement”) to become effective on August 14, 2023, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, The Crone Law Group, PC, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Securities Act, we, as representative of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very
truly yours,
SPARTAN
CAPITAL SECURITIES, LLC.

Show Raw Text
CORRESP
1
filename1.htm

August
9, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Inspire
    Veteniary Partners, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333- 271198

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Spartan Capital Securities, LLC,
as representative of the several underwriters, hereby joins Inspire Veteniary Partners Inc., (the “Company”) in requesting
that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-
271198) (the “Registration Statement”) to become effective on August 14, 2023, at 5:00 p.m., Eastern Time, or as soon thereafter
as practicable, or at such other time as the Company or its outside counsel, The Crone Law Group, PC, request by telephone that such
Registration Statement be declared effective.

Pursuant
to Rule 460 under the Securities Act, we, as representative of the several underwriters, wish to advise you that there will be distributed
to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of
the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The
undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters
and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.

    Very
    truly yours,

    SPARTAN
    CAPITAL SECURITIES, LLC.

    By:
    /s/ Brian Duddy

    Name:
    Brian
    Duddy

    Title:
    Director
    Capital Markets